First PET Imaging Studies With 63 Zn-Zinc Citrate in Healthy Human Participants and Patients With Alzheimer Disease
- Mayo Clinic, Rochester, MN (United States). Dept. of Radiology; Mayo Clinic Rochester
- Mayo Clinic, Rochester, MN (United States). Dept. of Radiology
- Mayo Clinic, Rochester, MN (United States). Dept. of Health Sciences Research
- Mayo Clinic, Rochester, MN (United States). Dept. of Neurology
Abnormalities in zinc homeostasis are indicated in many human diseases, including Alzheimer disease (AD). 63Zn-zinc citrate was developed as a positron emission tomography (PET) imaging probe of zinc transport and used in a first-in-human study in 6 healthy elderly individuals and 6 patients with clinically confirmed AD. A dynamic PET imaging of the brain was performed for 30 minutes following intravenous administration of 63Zn-zinc citrate (~330 MBq). Subsequently, body PET images were acquired. Urine and venous blood were analyzed to give information on urinary excretion and pharmacokinetics. Regional cerebral 63Zn clearances were compared with 11C-Pittsburgh Compound B (11C-PiB) and 18F-fluorodeoxyglucose (18F-FDG) imaging data. 63Zn-zinc citrate was well tolerated in human participants with no adverse events monitored. Tissues of highest uptake were liver, pancreas, and kidney, with moderate uptake being seen in intestines, prostate (in males), thyroid, spleen, stomach, pituitary, and salivary glands. Moderate brain uptake was observed, and regional dependencies were observed in 63Zn clearance kinetics in relationship with regions of high amyloid-β plaque burden (11C-PiB) and 18F-FDG hypometabolism. In conclusion, zinc transport was successfully imaged in human participants using the PET probe 63Zn-zinc citrate. Primary sites of uptake in the digestive system accent the role of zinc in gastrointestinal function. Preliminary information on zinc kinetics in patients with AD evidenced regional differences in clearance rates in correspondence with regional amyloid-β pathology, warranting further imaging studies of zinc homeostasis in patients with AD.
- Research Organization:
- Mayo Clinic, Rochester, MN (United States)
- Sponsoring Organization:
- AVID Radiopharmaceuticals, Philadelphia, PA (United States); Elsie and Marvin Dekelboum Family Foundation; GE Healthcare, Little Chalfont (United Kingdom); National Institute on Aging; Siemens Molecular Imaging, Inc, Knoxville, TN (United States); USDOE Office of Science (SC), Biological and Environmental Research (BER) (SC-23). Biological Systems Science Division
- Grant/Contract Number:
- SC0008947
- OSTI ID:
- 1423938
- Journal Information:
- Molecular Imaging, Journal Name: Molecular Imaging Journal Issue: 1-10 Vol. 15; ISSN 1536-0121
- Publisher:
- SAGECopyright Statement
- Country of Publication:
- United States
- Language:
- English
A Novel Microtubule-Tau Association Enhancer and Neuroprotective Drug Candidate: Ac-SKIP
|
journal | October 2019 |
Across the spectrum: integrating multidimensional metal analytics for in situ metallomic imaging
|
journal | January 2019 |
Production of radiometals in liquid targets
|
journal | January 2020 |
Zinc Chloride Exposure Inhibits Brain Acetylcholine Levels, Produces Neurotoxic Signatures, and Diminishes Memory and Motor Activities in Adult Zebrafish
|
journal | October 2018 |
Similar Records
Tau covariance patterns in Alzheimer's disease patients match intrinsic connectivity networks in the healthy brain
Tau PET and multimodal brain imaging in patients at risk for chronic traumatic encephalopathy
Multimodal Imaging of Alzheimer Pathophysiology in the Brain's Default Mode Network
Journal Article
·
Wed May 01 20:00:00 EDT 2019
· NeuroImage: Clinical
·
OSTI ID:1604668
Tau PET and multimodal brain imaging in patients at risk for chronic traumatic encephalopathy
Journal Article
·
Wed Oct 16 20:00:00 EDT 2019
· NeuroImage: Clinical
·
OSTI ID:1599790
Multimodal Imaging of Alzheimer Pathophysiology in the Brain's Default Mode Network
Journal Article
·
Fri Dec 31 19:00:00 EST 2010
· International Journal of Alzheimer's Disease
·
OSTI ID:1198463